STAT+: CMS signals intent to revamp how it pays for clinical software and AI
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- CMS proposed 2027 hospital outpatient and physician fee rules designed to build a more consistent payment structure for clinical software and AI that accounts for their impact on patient outcomes.
- The agency's first move is an interim step for 2027 that changes how it labels and pays for several clinical software and AI services, rather than a full restructuring.
- Medicare has historically been effective at pricing tangible items — from cotton swabs to CT scanner wear and tear — but has struggled to value algorithm-based tools like AI that predicts cardiac risk from CT scans or maps prostate cancer's spread.
- The proposal represents the latest chapter in years of Medicare wrestling with how to reimburse AI and software-driven clinical tools whose value is tied to outputs rather than physical inputs.
- The story is Part 3 of STAT's "Paying for AI" series, examining how clinical AI tools influence health care affordability and patient outcomes.
Why it matters: For developers of clinical AI, the 2027 labeling change is the first concrete CMS step toward a reimbursement framework that recognizes patient-outcome value over physical-input cost — but the interim nature of the proposal means the bigger payment overhaul is still ahead, leaving pricing uncertainty for algorithm-based diagnostics and decision-support tools.
